Product NDC: | 61748-024 |
Proprietary Name: | Ethosuximide |
Non Proprietary Name: | Ethosuximide |
Active Ingredient(s): | 250 mg/5mL & nbsp; Ethosuximide |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61748-024 |
Labeler Name: | VersaPharm Incorporated |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040506 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040101 |
Package NDC: | 61748-024-16 |
Package Description: | 473 mL in 1 BOTTLE, PLASTIC (61748-024-16) |
NDC Code | 61748-024-16 |
Proprietary Name | Ethosuximide |
Package Description | 473 mL in 1 BOTTLE, PLASTIC (61748-024-16) |
Product NDC | 61748-024 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ethosuximide |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20040101 |
Marketing Category Name | ANDA |
Labeler Name | VersaPharm Incorporated |
Substance Name | ETHOSUXIMIDE |
Strength Number | 250 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |